Trade Summary

2 days ago, Klein Matthew B., serving as CEO at Ptc Therapeutics, Inc. (PTCT), sold 12,572 shares at $72.95 per share, for a total transaction value of $917,154.00. Following this transaction, Klein Matthew B. now holds 393,998 shares of PTCT.

This sale represents a 3.00% decrease in Klein Matthew B.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 15, 2026 at 5:20 PM ET, 1 day after the trade was made.

Ptc Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.